The positivity rate stands at 4.39 per cent, the fifth straight day that it is below the 5 per cent-mark.
Witnessing a decline in Covid-19 cases, India today reported it’s lowest infections in 70 days with the country adding 84,332 new cases to take its overall caseload to 2.93 crore. 3.68 per cent of total infections account for active cases.
The country’s positivity rate has also shown a downward trend. The positivity rate stands at 4.39 per cent, the fifth straight day that it is below the 5 per cent-mark.
In the last 24 hours, active cases have decreased by 40,981, taking the tally to less than 11 lakhs (10,80,690) after 63 days. According to the government, the national COVID-19 recovery rate has improved to 95.07 per cent.
However, the country continues record significant number of covid-related deaths with 4,002 fatalities being reported in the last 24 hours.
Tamil Nadu leads in reporting highest daily cases with 15,759 people found infected in the state, followed by neighbouring Kerala (14,233 cases) and Karnataka (8,249 cases).
The worst-hit state by the pandemic, Maharashtra reported 11,766 cases, taking its overall tally to 58.87 lakh.
In Delhi, the total number of actives cases has gone down below 4,000, with the city recording 238 new cases of COVID-19 and 504 recoveries.
Dr Anthony Fauci, the medical advisor to the US President, has claimed that extending intervals between vaccine doses could leave people vulnerable to infection by one of the Covid variants in circulation. “The problem with extending intervals is that you become vulnerable to variants. We’ve seen that in the UK, where they extended that interval, in that period you can get infected by the variants,” Dr Fauci told NDTV.
Underlining that reducing the time gap requires proper scientific study in the Indian scenario, the government Friday said there is no need to panic on the need for an immediate change in the dosage interval of Covishield vaccine.
In light of the variants in circulation, some media reports quoted recent studies that it would be better to shorten the gap between two doses of Covishield vaccine. Dr V K Paul, member (Health) at NITI Aayog, said there is a need to balance such concerns.
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.
